ResearcherInstitute of Cancer ResearchActive in the last 2 years
Huafu Li
Matched on ORCID iD 0009-0003-0290-3529; OpenAlex author ID A5065104542. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 3
- A Jagged1-regulated hybrid-EMT state identifies pancreatic cancer stem cells. First author DOI 10.1016/j.celrep.2025.116909↗
- SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. Co-author DOI 10.1038/s41586-025-09574-y↗
- GREM1 is required to maintain cellular heterogeneity in pancreatic cancer. Co-author DOI 10.1038/s41586-022-04888-7↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Linxiang Lan · 3 shared papers, 2022–2026 · strength 0.59
- Paper A Jagged1-regulated hybrid-EMT state identifies pancreatic cancer stem cells. DOI 10.1016/j.celrep.2025.116909↗
- Paper SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. DOI 10.1038/s41586-025-09574-y↗
- Paper GREM1 is required to maintain cellular heterogeneity in pancreatic cancer. DOI 10.1038/s41586-022-04888-7↗
- Axel Behrens · 3 shared papers, 2022–2026 · strength 0.59
- Paper A Jagged1-regulated hybrid-EMT state identifies pancreatic cancer stem cells. DOI 10.1016/j.celrep.2025.116909↗
- Paper SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. DOI 10.1038/s41586-025-09574-y↗
- Paper GREM1 is required to maintain cellular heterogeneity in pancreatic cancer. DOI 10.1038/s41586-022-04888-7↗
- Jessica Kristine Nelson · 2 shared papers, 2022–2025 · strength 0.31
- Anguraj Sadanandam · 2 shared papers, 2022–2025 · strength 0.31
- Tingzhuang Yi · 1 shared paper, 2025 · strength 0.19
- Theodore Evan · 1 shared paper, 2022 · strength 0.12
- Yoh Zen · 1 shared paper, 2022 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.